Drug Trial Radar · NCT06663358
A Multi-Country Observational Study of Safety and Effectiveness of Elfabrio® in Fabry Patients
Last checked: Nov 20, 2026Latest source record: Nov 14, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
100
Planned (sponsor's estimate)
Start
Nov 6, 2024
Primary completion
Nov 2029
Study completion Nov 2029
Sponsor
- Lead sponsor
- Chiesi Farmaceutici S.p.A.Industry
- Sponsor type
- Industry
- First posted
- Oct 29, 2024
Design
- Study type
- Observational
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A multi-centre, multi-country, observational, non-interventional, retrospective and prospective (hybrid) study among Fabry disease participants treated with pegunigalsidase alfa (Elfabrio®) in routine clinical care.
Conditions
- Fabry Disease
Interventions
Pegunigalsidase-alfaDrug
Administered via intravenous (IV) infusion under conditions of routine clinical care
Primary outcomes
What the sponsor says the trial is designed to measure.
- Estimated Glomerular Filtration Rate (eGFR)Time frame: 4 years
- Plasma Globotriaosylsphingosine (LysoGb3) ConcentrationTime frame: 4 years
- Left Ventricular Mass Index (LVMI; g/m2)Time frame: 4 years
- High Sensitivity Troponin (hs-cTnT)Time frame: 4 years
- Safety AssessmentsTime frame: 4 years
Locations
10 sites in 3 countries. Site status is shown where the registry gives one.
University of Alabama at Birmingham
Birmingham, Alabama · Recruiting
Emory University School of Medicine
Atlanta, Georgia · Recruiting
Northwestern University - Feinberg School of Medicine - Ann & Robert H. Lurie Children's Hospital of Chicago
Chicago, Illinois · Recruiting
University of Iowa Hospitals and Clinics
Iowa City, Iowa · Recruiting
Infusion Associates
Grand Rapids, Michigan · Recruiting
Lysosomal & Rare Disorder Research & Treatment Center (LRDRTC)
Fairfax, Virginia · Recruiting
General Hospital Slovenj Gradec
Slovenj Gradec, Slovenia · Recruiting
The Royal Free Hospital
London, United Kingdom · Recruiting
University Hospitals Birmingham NHS Foundation Trust, Queen Elizabeth Hospital
Edgbaston, Birmingham, United Kingdom · Recruiting
Salford Royal
Salford, Greater Manchester, United Kingdom · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.